Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

ClinicalTrials.gov ID: NCT04296864

Public ClinicalTrials.gov record NCT04296864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Study identification

NCT ID: NCT04296864
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Andover Eye Associates; Industry
Enrollment: 42 participants

Conditions and interventions

Conditions

Atopic Keratoconjunctivitis

Interventions

Dupilumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 9, 2020
Primary completion: Dec 31, 2024
Completion: Dec 31, 2024
Last update posted: Jan 29, 2024

2020 – 2025

United States locations

U.S. sites: 20
U.S. states: 14
U.S. cities: 20

Facility	City	State	ZIP	Site status
Premiere Practice Management, LLC	Los Angeles	California	90013	Recruiting
Colorado Eye Consultants/Corneal Consultants of Colorado	Littleton	Colorado	80120	Recruiting
Encore Medical Research, LLC	Hollywood	Florida	33021	Completed
Kannar Eye Care	Pittsburg	Kansas	66762	Recruiting
Andover Eye Associates	Andover	Massachusetts	01810	Recruiting
University of Michigan- Kellogg Eye Center	Ann Arbor	Michigan	48105	Withdrawn
Silverstein Eye Centers	Kansas City	Missouri	64133	Recruiting
Mercy Clinic Eye Specialists	Springfield	Missouri	65804	Recruiting
Ophthalmology Associates	St Louis	Missouri	63131	Recruiting
St. Louis Eye Institute	Town and Country	Missouri	63017	Recruiting
Northwell Health Physician Partners Ophthalmology at Great Neck	Great Neck	New York	11021	Completed
Gerald W. Zaidman, MD	Hawthorne	New York	10532	Recruiting
NC Eye Associates	Apex	North Carolina	27502	Recruiting
Vita Eye Clinic	Shelby	North Carolina	28150	Recruiting
Tracie Malsom	Fargo	North Dakota	58103	Recruiting
Vantage EyeCare, LLC.	Bala-Cynwyd	Pennsylvania	19004	Recruiting
Blink Research Center	Memphis	Tennessee	38119	Recruiting
Advancing Vision Research, LLC	Smyrna	Tennessee	37167	Recruiting
Eye Associates of Central Texas	Round Rock	Texas	78681	Withdrawn
Periman Eye Institute	Seattle	Washington	98119	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04296864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 29, 2024 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04296864 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →